Jasper Therapeutics JSPR
NASDAQ JSPR
$0.50 +0.00 (+0.44%)
As of: Oct 21, 2026 · 10:09 AM EDT

Jasper Therapeutics (JSPR) Change in Receivables (2023)

Updated

Jasper Therapeutics' Change in Receivables was -$663,000 in FY2023, compared with $663,000 in FY2022.

Analysis

Jasper Therapeutics (JSPR) Change in Receivables (2023) Analysis & Trends

  • Per Business Quant data, Change in Receivables in earlier years was $663,000 in FY2022 and -$600,000 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Eli Lilly 1,129.39 Bn 1,097.98 Bn 19.71 Bn -
2 Johnson & Johnson 615.68 Bn 534.21 Bn 17.26 Bn 1.35 Bn
3 AbbVie 505.77 Bn 478.89 Bn 12.70 Bn 1.37 Bn
4 Merck 366.50 Bn 320.88 Bn 12.21 Bn -
5 Novartis Ag 297.33 Bn 261.32 Bn 11.24 Bn -
6 Astrazeneca 261.02 Bn 234.71 Bn 12.86 Bn -
7 Amgen 235.47 Bn 190.87 Bn 7.24 Bn 1.09 Bn
8 Gilead Sciences 189.20 Bn 163.40 Bn 6.22 Bn 333.00 Mn
9 Pfizer 170.20 Bn 116.85 Bn 10.94 Bn -
10 Jasper Therapeutics 14.40 Mn -112.01 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 -663,000.00
API Access

Jasper Therapeutics Change in Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-receivables&ticker=JSPR&period=max&api_key=YOUR_API_KEY